A major focus of the Terry Fox Research Institute is translational research. Translation is often defined as research which moves discoveries made in the clinic to the laboratory and thence back to the bedside. It is sometimes called “applied” research. This area of research holds great promise today for providing improved care and outcomes for cancer patients everywhere. Translational research is focused on speeding up the development and adoption of new treatments and technologies for the benefit of cancer patients and their families, the healthcare system and for the population at large. It covers the spectrum of cancer research from early detection and screening to diagnosis, treatment and monitoring of treatment. Translational research has been underfunded in the past partly because it is complex, involves many different disciplines and stakeholders, and is usually expensive to do.
Please refer to the table below for the current portfolio of TFRI translational projects. Additional information for each can be found in the Canadian Research Information System (CRIS) database.
A Strategic Opportunity for the TFRI Translational Program is now launched annually. Information on the 2018 Strategic Opportunity will be published in early May, 2017.
Previous Funding Competition
The 2016 Strategic Opportunity closed to applications in 2015. More information about the status of this competition can be found on the Translational Program (2016) page.
Below are meeting reports from recent meetings and workshops related to our translational research projects.
Pancreatic Cancer Workshop Meeting Report - September 2015